Inspire Medical Systems, Inc. (INSP) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Inspire Medical Systems’s revenue went from $16M in fiscal 2016 to $912M in fiscal 2025, growth of about 56.3% a year.
Net income in fiscal 2025 was $145M, a net margin of 15.9%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $881M and net income $101M.
Free cash flow was $78M in fiscal 2025 and positive in 4 of the 10 years shown.
The diluted share count rose 2615% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $881M | $912M | $803M | $625M | $408M | $233M | $115M | $82M | $51M | $29M | $16M |
| Gross profit | $759M | $779M | $680M | $528M | $342M | $200M | $98M | $68M | $41M | $23M | $13M |
| Operating income | $16M | $51M | $36M | -$40M | -$48M | -$40M | -$56M | -$35M | -$20M | -$16M | -$17M |
| Net income | $101M | $145M | $54M | -$21M | -$45M | -$42M | -$57M | -$33M | -$22M | -$18M | -$19M |
| EPS (diluted) | $3.36 | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 | $-2.19 | $-1.40 | $-1.50 | $-14.88 | $-16.90 |
| R&D | $98M | $103M | $114M | $117M | $69M | $37M | $26M | $13M | $7M | $6M | $7M |
| Revenue growth | — | +13.6% | +28.5% | +53.2% | +74.8% | +102.3% | +40.6% | +62.2% | +77.1% | +73.9% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $135M | $117M | $130M | $25M | $12M | -$20M | -$53M | -$33M | -$19M | -$16M | -$18M |
| Capital spending | -$37M | -$38M | -$39M | -$24M | -$9M | -$5M | -$2M | -$3M | -$250000 | -$412000 | -$306000 |
| Free cash flow | $98M | $78M | $91M | $1M | $2M | -$25M | -$56M | -$36M | -$19M | -$16M | -$18M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $50M | $175M | $0 | $0 | $0 | — | — | — | — | — | — |
| Stock-based pay | $117M | $130M | $116M | $82M | $52M | $26M | $13M | $6M | $1M | $243000 | $248000 |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $308M | $446M | $460M | $451M | $214M | $234M | $149M | $188M | $16M | $7M |
| Debt | — | $32M | $32M | $25M | $9M | $34M | $31M | $25M | $27M | $16M | — |
| Equity | — | $781M | $690M | $573M | $496M | $229M | $230M | $140M | $164M | $1M | -$7M |
| Total assets | — | $907M | $808M | $677M | $565M | $295M | $281M | $181M | $200M | $25M | — |
| Shares (diluted) | 29M | 30M | 31M | 29M | 28M | 27M | 26M | 24M | 15M | 1M | 1M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 86.2% | 85.4% | 84.7% | 84.5% | 83.8% | 85.7% | 84.7% | 83.4% | 80.1% | 78.9% | 76.2% |
| Operating margin | 1.8% | 5.6% | 4.5% | -6.5% | -11.7% | -17.1% | -48.7% | -42.5% | -40.3% | -56.0% | -105.0% |
| Net margin | 11.4% | 16.0% | 6.7% | -3.4% | -11.0% | -18.0% | -49.6% | -40.5% | -43.1% | -61.3% | -112.8% |
| FCF margin | 11.1% | 8.6% | 11.3% | 0.2% | 0.6% | -10.6% | -48.1% | -43.4% | -37.4% | -56.7% | -111.1% |
| ROIC | — | 5.0% | 4.6% | -5.3% | -7.4% | -12.0% | -17.1% | -16.7% | -10.7% | -90.0% | — |
| ROE | — | 18.6% | 7.8% | -3.7% | -9.0% | -18.4% | -24.9% | -23.8% | -13.3% | -1319.6% | 280.4% |
Frequently asked questions
What is Inspire Medical Systems’s annual revenue?
$912M in fiscal 2025 and $881M over the twelve months to September 30, 2026.
How much profit does Inspire Medical Systems make?
Net income was $145M in fiscal 2025 (net margin 15.9%).
Is Inspire Medical Systems’s revenue growing?
Yes: revenue rose 13.6% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.